Cargando…

Ocular manifestations in Iranian patients referred to rheumatology clinics from 2018 to 2020

AIM: Autoimmune diseases are presented with many signs and symptoms. Eyes are commonly involved in these diseases. This study aimed to estimate the prevalence of different ophthalmological complications in patients with and without immune‐mediated rheumatological diseases. METHODS: Patients who were...

Descripción completa

Detalles Bibliográficos
Autores principales: Pournazari, Meharan, Hashemi, Tara, Zarpoosh, Mahsa, Amirian, Parsa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10165950/
https://www.ncbi.nlm.nih.gov/pubmed/37249299
http://dx.doi.org/10.1002/iid3.863
_version_ 1785038345725804544
author Pournazari, Meharan
Hashemi, Tara
Zarpoosh, Mahsa
Amirian, Parsa
author_facet Pournazari, Meharan
Hashemi, Tara
Zarpoosh, Mahsa
Amirian, Parsa
author_sort Pournazari, Meharan
collection PubMed
description AIM: Autoimmune diseases are presented with many signs and symptoms. Eyes are commonly involved in these diseases. This study aimed to estimate the prevalence of different ophthalmological complications in patients with and without immune‐mediated rheumatological diseases. METHODS: Patients who were referred to Kermanshah's rheumatologic clinics by an ophthalmologist from 2018 to 2020 for a rheumatologist visit were included. A checklist for extracting data from medical files; containing symptoms, organ involvement, ocular diseases diagnosed by an ophthalmologist, rheumatologic diseases diagnosed by a rheumatologist, lab tests, and disease progression was created. After we evaluated the medical data, we found that 54 patients out of 106 were diagnosed to have immune‐mediated rheumatological diseases. Patients were divided into two groups; the first group included patients with diagnosed immune‐mediated rheumatologic disease and ophthalmic complications; patients with no known immune‐mediated rheumatological disease were considered the second group. The obtained information was analyzed using statistical tests. RESULTS: One hundred and six patients participated in this study, 67% of whom were females. The most common ocular symptom was blurred vision (49%). Involvement of both eyes (43.4%) was more common than single left or right eye involvement. The most common ophthalmic disease was anterior uveitis (35.8%). The most common rheumatologic disease was Behçet's disease (21.7%). Hypertension and hypothyroidism were the most common comorbidities; 36.7% of the patients had skin and mucous involvement, and 37.7% had joint involvement. In follow‐up of the ophthalmic symptoms, most patients were controlled partially. Ophthalmic diseases, laboratory tests, joint involvement, skin and mucous involvement, and lung involvement were associated with rheumatologic diseases. CONCLUSION: Early diagnosis of ocular involvement in rheumatologic diseases is crucial to prevent adverse complications. The results can be beneficial for a better perception of ophthalmic symptoms and diseases among patients with autoimmune diseases.
format Online
Article
Text
id pubmed-10165950
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-101659502023-05-09 Ocular manifestations in Iranian patients referred to rheumatology clinics from 2018 to 2020 Pournazari, Meharan Hashemi, Tara Zarpoosh, Mahsa Amirian, Parsa Immun Inflamm Dis Original Articles AIM: Autoimmune diseases are presented with many signs and symptoms. Eyes are commonly involved in these diseases. This study aimed to estimate the prevalence of different ophthalmological complications in patients with and without immune‐mediated rheumatological diseases. METHODS: Patients who were referred to Kermanshah's rheumatologic clinics by an ophthalmologist from 2018 to 2020 for a rheumatologist visit were included. A checklist for extracting data from medical files; containing symptoms, organ involvement, ocular diseases diagnosed by an ophthalmologist, rheumatologic diseases diagnosed by a rheumatologist, lab tests, and disease progression was created. After we evaluated the medical data, we found that 54 patients out of 106 were diagnosed to have immune‐mediated rheumatological diseases. Patients were divided into two groups; the first group included patients with diagnosed immune‐mediated rheumatologic disease and ophthalmic complications; patients with no known immune‐mediated rheumatological disease were considered the second group. The obtained information was analyzed using statistical tests. RESULTS: One hundred and six patients participated in this study, 67% of whom were females. The most common ocular symptom was blurred vision (49%). Involvement of both eyes (43.4%) was more common than single left or right eye involvement. The most common ophthalmic disease was anterior uveitis (35.8%). The most common rheumatologic disease was Behçet's disease (21.7%). Hypertension and hypothyroidism were the most common comorbidities; 36.7% of the patients had skin and mucous involvement, and 37.7% had joint involvement. In follow‐up of the ophthalmic symptoms, most patients were controlled partially. Ophthalmic diseases, laboratory tests, joint involvement, skin and mucous involvement, and lung involvement were associated with rheumatologic diseases. CONCLUSION: Early diagnosis of ocular involvement in rheumatologic diseases is crucial to prevent adverse complications. The results can be beneficial for a better perception of ophthalmic symptoms and diseases among patients with autoimmune diseases. John Wiley and Sons Inc. 2023-05-08 /pmc/articles/PMC10165950/ /pubmed/37249299 http://dx.doi.org/10.1002/iid3.863 Text en © 2023 The Authors. Immunity, Inflammation and Disease published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Pournazari, Meharan
Hashemi, Tara
Zarpoosh, Mahsa
Amirian, Parsa
Ocular manifestations in Iranian patients referred to rheumatology clinics from 2018 to 2020
title Ocular manifestations in Iranian patients referred to rheumatology clinics from 2018 to 2020
title_full Ocular manifestations in Iranian patients referred to rheumatology clinics from 2018 to 2020
title_fullStr Ocular manifestations in Iranian patients referred to rheumatology clinics from 2018 to 2020
title_full_unstemmed Ocular manifestations in Iranian patients referred to rheumatology clinics from 2018 to 2020
title_short Ocular manifestations in Iranian patients referred to rheumatology clinics from 2018 to 2020
title_sort ocular manifestations in iranian patients referred to rheumatology clinics from 2018 to 2020
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10165950/
https://www.ncbi.nlm.nih.gov/pubmed/37249299
http://dx.doi.org/10.1002/iid3.863
work_keys_str_mv AT pournazarimeharan ocularmanifestationsiniranianpatientsreferredtorheumatologyclinicsfrom2018to2020
AT hashemitara ocularmanifestationsiniranianpatientsreferredtorheumatologyclinicsfrom2018to2020
AT zarpooshmahsa ocularmanifestationsiniranianpatientsreferredtorheumatologyclinicsfrom2018to2020
AT amirianparsa ocularmanifestationsiniranianpatientsreferredtorheumatologyclinicsfrom2018to2020